Cart
sales@molnova.com
M4 mAChR agonist-1?
CAS No. 785705-53-5
M4 mAChR agonist-1?( 4-Piperidinecarboxamide, 1-(5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)- )
Catalog No. M28954 CAS No. 785705-53-5
M4 mAChR agonist-1 is an effective agonist of M4 mAChR (EC50 >10 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 37 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 269 | In Stock |
|
| 100MG | 398 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 901 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameM4 mAChR agonist-1?
-
NoteResearch use only, not for human use.
-
Brief DescriptionM4 mAChR agonist-1 is an effective agonist of M4 mAChR (EC50 >10 μM).
-
DescriptionM4 mAChR agonist-1 is an effective agonist of M4 mAChR (EC50 >10 μM).
-
In Vitro——
-
In Vivo——
-
Synonyms4-Piperidinecarboxamide, 1-(5,6-dimethylthieno[2,3-d]pyrimidin-4-yl)-
-
PathwayCell Cycle/DNA Damage
-
TargetAChR
-
RecptorParasite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number785705-53-5
-
Formula Weight290.389
-
Molecular FormulaC14H18N4OS
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20 mg/mL (68.88 mMul)
-
SMILESCC1=C(C)C2=C(N=CN=C2S1)N1CCC(CC1)C(N)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.G?tz MG, et al. Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens. J Med Chem. 2008 May 8;51(9):2816-32.
molnova catalog
related products
-
NS9283
NS9283, a positive allosteric modulator selective for the α4β2 form, reduces ethanol consumption.
-
GAT107
GAT107 is a novel and potent α7 nicotinic cholinergic receptor modifier agonist and modulator with anti-inflammatory activity that reverses injury perception in a mouse model of neuropathic pain.
-
CP-810123
CP-810123 is a new alpha 7 nAChR agonist for the treatment of cognitive impairment associated with psychiatric or neurological disorders such as schizophrenia and Alzheimer's disease.
